BOZZO, FRANCESCA

BOZZO, FRANCESCA  

Dip. MEDICINA ED ONCOLOGIA SPERIMENTALE (attivo dal 01/01/1900 al 30/04/2013)  

Mostra records
Risultati 1 - 20 di 21 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autore(i) File
A Cla response of Human Breast cancer cells: mechanisms involved 2008 Bocca C; Bozzo F; Cannito S; Colombatto S; Miglietta A.
A Signal cross-talk between PPARgamma and E-cadherin/beta-catenin system modulates CLA response of human breast cancer cells 2007 Bocca C; Bozzo F; Miglietta A.
An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines 2004 MAGGIORA M; BOLOGNA M; CERU' MP; POSSATI L; ANGELUCCI A; CIMINI A; MIGLIETTA A; BOZZO F; MARGIOTTA C; MUZIO G; CANUTO R
Antiproliferative effect of a novel nitro-oxy derivative of celecoxib in human colon cancer cells: role of COX-2 and nitric oxide. 2010 Bocca C; Bozzo F; Bassignana A; Miglietta A.
Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines. 2011 C. Bocca; F. Bozzo; A. Bassignana; A. Miglietta
Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells 2012 Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A
CLA reduces breast cancer cell growth and invasion through ERα and PI3K/Akt pathways 2010 Bocca C; Bozzo F; Cannito S; Colombatto S; Miglietta A.
Coinvolgimento della via MAPK e di PPARg nell’effetto antiproliferativo dell’acido linoleico coniugato in cellule umane di carcinoma del colon 2006 Bozzo F; Bocca C; Miglietta A.
Conjugated linoleic acid induces apoptosis in MDA-MB-231 breast cancer cells through ERK/MAPK signalling and mitochondrial pathway 2006 A. MIGLIETTA; F. BOZZO; C. BOCCA; L. GABRIEL; A. TROMBETTA; S. BELOTTI; R.A. CANUTO
COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers. 2010 Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C.
COX2 inhibitor NS398 reduces HT-29 cell invasiveness by modulating signaling pathways mediated by EGFR and HIF1-α 2014 Bocca C; Bozzo F; Miglietta A
EXPRESSION OF COX-2 IN HUMAN BREAST CANCER CELLS AS A CRITICAL DETERMINANT OF EPITHELIAL-MESENCHYMAL TRANSITION AND INVASIVENESS 2014 C. BOCCA; M. IEVOLELLA; R. AUTELLI; M. MOTTA; L. MOSSO; B. TORCHIO; F. BOZZO; S. CANNITO; C. PATERNOSTRO; S. COLOMBATTO; M. PAROLA; A. MIGLIETTA
Inhibitory effect of conjugated linoleic acid on the growth of breast cancer cells 2004 Miglietta A; Bozzo F; Bocca C; Belotti S; Gabriel L; Canuto RA.
Insulin can modulate MCF-7 cell response to paclitaxel 2004 MIGLIETTA A; PANNO ML; BOZZO F; L. GABRIEL; BOCCA C
Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells 2008 Bocca C; Bozzo F; Martinasso G; Canuto RA; Miglietta A.
Meccanismi alla base dell' effetto antiproliferativo e proapoptoticodell' acido linoleico coniugato in cellule di tumore mammario 2005 Bozzo F; Bocca C; Gabriel L; Canuto RA; Miglietta A.
Modulation of MDA-MB-231 breast cancer cell proliferation and apoptosis by linoleic acid and conjugated linoleic acid 2004 Miglietta A; Bocca C; Bozzo F; Gabriel L; Canuto RA
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth 2009 Bozzo F; Bassignana A; Lazzarato L; Boschi D; Gasco A; Bocca C; Miglietta A.
A NOVEL NITRO-OXY SUBSTITUTED ANALOGUE OF ROFECOXIB REDUCES HUMAN COLON CANCER CELL GROWTH 2012 Claudia BOCCA; Francesca BOZZO; Monica IEVOLELLA; Antonella MIGLIETTA
Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells 2008 Cannito S; Novo E; Compagnone A; Valfrè di Bonzo L; Busletta C; Zamara E; Paternostro C; Povero D; Bandino A; Bozzo F; Cravanzola C; Bravoco V; Colombatto S; Parola M.